Kusatsu, Japan

Hideo Sugi


Average Co-Inventor Count = 5.7

ph-index = 8

Forward Citations = 201(Granted Patents)


Location History:

  • Moriyama, JP (1983 - 1991)
  • Shiga, JP (1991)
  • Kusatsu, JP (1989 - 1996)

Company Filing History:


Years Active: 1983-1996

Loading Chart...
22 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Hideo Sugi

Introduction: Hideo Sugi is a notable inventor based in Kusatsu, Japan, recognized for his significant contributions to the field of medicinal chemistry. With a remarkable portfolio of 22 patents, Sugi has been at the forefront of developing innovative pharmaceutical compounds, particularly for treating complex diseases such as rheumatoid arthritis. His work exemplifies the intersection of chemistry and therapeutic application.

Latest Patents: Among his recent inventions, Hideo Sugi has patented the synthesis and application of diaminotrifluoromethylpyridine derivatives. His patented method for treating rheumatoid arthritis involves the use of these derivatives, with specific chemical formulations that advance pharmaceutical therapies. The detailed nature of these compounds reflects a thorough understanding of molecular interactions and therapeutic potentials, aiming to enhance treatment efficacy for patients suffering from autoimmune conditions.

Career Highlights: Hideo Sugi has made significant strides in his career by working with reputable organizations such as Ishihara Sangyo Kaisha, Ltd. and The Green Cross Corporation. His experiences at these companies provided him with a platform to collaborate and innovate, resulting in multiple patents that address crucial healthcare challenges. His impressive patent record underscores his expertise and dedication in his field.

Collaborations: Throughout his career, Sugi has collaborated with esteemed colleagues, including Takahiro Haga and Nobutoshi Yamada. These partnerships have fostered an environment of shared knowledge and skills, contributing to the successful development of cutting-edge pharmaceuticals. The synergy among talented professionals in this domain is vital to the advancement of innovative treatments.

Conclusion: Hideo Sugi’s contributions to the field of innovation in medicinal chemistry are commendable. With his extensive patent portfolio and collaborative efforts, he continues to influence drug development and therapeutic strategies. His work not only addresses pressing medical needs but also inspires future inventors to pursue transformative solutions in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…